Adam Elsesser is the CEO and co-founder of Penumbra, Inc., a company dedicated to innovative medical solutions. Born in 1977, he earned an MBA from Harvard Business School and has played a crucial role in the company's success since its...

Current Market Cap

$7.43B

Number of Employees

4.2K

Total Compensation

2019 - 2023

Trending up by 0.00% last year
Showing total compensation for the last 2019 - 2023

Stock

Up by 0.00% last year

Salary

Up by 0.00% last year

Bonus

Up by 0.00% last year

Other

Up by 0.00% last year

Year

2023

Total Compensation

$601.62K

Salary

$600.00K

Board Justification

The company maintains a simple executive compensation program focused on base salary and equity ownership, with no cash bonuses or other short-term incentives, aligning long-term interests with those of stockholders.

Bonus

$0.00

Board Justification

No cash bonuses or other short-term cash incentive compensation were provided in 2023.

Other

$1.62K

Board Justification

Includes life insurance and short-term and long-term disability insurance premium payments.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock awards vested in 2023 as the CEO did not receive any new equity grants or increases in cash compensation.

Performance Metrics

The CEO's compensation is linked to the company's performance metrics, including revenue and non-GAAP income from operations.

SEC Filing

From April 24, 2024

Adam Elsesser

CEO of Penumbra

P

Education

MBA from Harvard Business School

Field of Expertise

Business & Management

Born

January 1, 1977 - 47 years ago

Is Founder?

No

Current Tenure

9 years 9 months (Jan 2015 - Present)

Previous Experience

President of Penumbra, Inc. from January 2015 to August 2019

View Holdings

Insider Holdings of Adam Elsesser

PEN

$171.25M

-$53.66M (-23.86%)

Last Insider Trade

PEN

$2.96M

PEN at $197.63/share

Sep 20, 2024

Sale